Oramed Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 04/30/2024
Oramed Pharmaceuticals Stock Forecast and Price Target
Oramed Pharmaceuticals's most recent price target of $4.25 for 2024 was provided by renowned analysts over the past few months, with an average prediction of $4.25. If this prediction is correct, Oramed Pharmaceuticals's stock could rise by 74.18 percent from its current trading price. The potential increase for the stock is $4.25 per share, with a possible range of $4.25 to $4.25. If interested in ORMP stock, you may also want to consider its competitors.
74.18% Upside
Oramed Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
Oramed Pharmaceuticals's Price has grown in the last three years, jumping from $0.00 to $0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will reach $2.62 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
Oramed Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030
Oramed Pharmaceuticals's Revenue has decreased by 0.37% In the last two years, from $2.71M to $2.70M. In the following year, the 1 analysts surveyed believe that Oramed Pharmaceuticals's Revenue will decrease by 25.93%, reaching $2.00M. According to professionals, by 2030, Oramed Pharmaceuticals's Revenue will have decreased by 100.00%, falling down to $0.00.
.jpg)
Oramed Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030
Oramed Pharmaceuticals's EBITDA has increased by 78.91% In the last two years, going from $-22.66M to $-40.54M. For the next year, 0 analysts project Oramed Pharmaceuticals's EBITDA to drop by 18.83%, reaching $-32.91M. By 2030, professionals believe that Oramed Pharmaceuticals's EBITDA will decrease by 16.84%, reaching $-33.71M – a concerning trend for the company.
Oramed Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Oramed Pharmaceuticals's EBIT has grown, increasing from $-22.68M to $-40.60M – a growth of 79.01%. According to 1 prominent analysts, Oramed Pharmaceuticals's EBIT will fall by 24.14% in the next year, reaching $-30.80M. Over the next seven years, experts anticipate that Oramed Pharmaceuticals's EBIT will grow at a rate of 38.42%.
Oramed Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
Oramed Pharmaceuticals's EPS has grown in the last three years, jumping from $-0.56 to $0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will reach $-0.74 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)